On November 15, 2022, AstraZeneca Belgium & Luxembourg launched its drug Farxiga in a new indication: chronic kidney disease. During the launch event, which was held at Studio 1 of Cmore Media Arena, exclusive information on the new role of SGLT2i in the treatment of chronic renal insufficiency is presented by prof. Hiddo lambers Heerspink, prof. Michel Jadoul and dr. Gert Meeus.

Because the shared information is specific for health care professionals, we do not show the full broadcast here.